We are live on ! Find out more
AGP

Artia Global Partners Portfolio holdings

AUM $499M
1-Year Est. Return 186.05%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+186.05%
3 Year Est. Return
+672.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$367M
AUM Growth
-$150M
Cap. Flow
-$146M
Cap. Flow %
-39.8%
Top 10 Hldgs %
78.79%
Holding
53
New
7
Increased
9
Reduced
5
Closed
8

Top Buys

Rank Stock Value
1
SLNO
Soleno Therapeutics
SLNO
+$8.62M
2
NVO
Novo Nordisk
NVO
+$6.67M
3
VKTX icon
Viking Therapeutics
VKTX
+$4.69M
4
RVMD icon
Revolution Medicines
RVMD
+$4.18M
5
MRUS
Merus
MRUS
+$1.57M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$54.8M
2
OCUL icon
Ocular Therapeutix
OCUL
+$3.42M
3
APGE icon
Apogee Therapeutics
APGE
+$2.3M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$2.06M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$1.49M

Sector Composition

Rank Sector Weight
1 Healthcare 96.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
51
Pliant Therapeutics
PLRX
$65M
– –
-50,000
Closed -$538K
SRPT icon
52
Sarepta Therapeutics
SRPT
$1.71B
– –
-2,600
Closed -$411K
VKTX icon
53
CALL
Viking Therapeutics
VKTX
$3.86B
– –
-150,000
Closed -$7.95M
1 2
3

Similar funds

MIP
Marietta Investment Partners Milwaukee, Wisconsin $499M AUM 41.06% 1-Year Est. Return
H2CM
H/2 Credit Manager Stamford, Connecticut $500M AUM 24.68% 1-Year Est. Return
HCI
Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return
KCL
KR Capital LP New York City, New York $499M AUM
PPC
Park Place Capital Homewood, Alabama $499M AUM 14.38% 1-Year Est. Return
HIC
Holderness Investments Company Greensboro, North Carolina $498M AUM 34.39% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
DAC
Dividend Assets Capital Ridgeland, South Carolina $501M AUM 13.71% 1-Year Est. Return

Artia Global Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Artia Global Partners held 53 positions worth $367M, down 29% from $517M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Artia Global Partners withdrew a net $146M in Q3 2024, closing 8 positions and reducing 5 holdings. Its most notable exit was Merck, an estimated $54.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 75% a quarter earlier.

Against the trend, Artia Global Partners opened a new position in Revolution Medicines worth $4.35M.

  • Artia Global Partners's largest Q3 2024 buy was Revolution Medicines: 95,885 shares worth $4.35M.
  • Artia Global Partners added most to Soleno Therapeutics in Q3 2024, an estimated $8.62M increase.
  • Artia Global Partners's biggest Q3 2024 reduction was Crinetics Pharmaceuticals, cutting an estimated $2.06M.
  • Artia Global Partners fully exited Merck in Q3 2024, selling an estimated $54.8M.
  • Artia Global Partners's ten largest holdings make up 79% of its $367M portfolio in Q3 2024.
  • Artia Global Partners opened 7 new positions and closed 8 in Q3 2024.
  • Artia Global Partners's portfolio value fell 29% quarter-over-quarter to $367M.

Based on Artia Global Partners's 13F filing for Q3 2024, filed 14 Nov 2024.